Concepedia

Author

Eduardo Molinari

Abbott Fund

Also Known As

E J Molinari, E Molinari, Eduardo J Molinari, Eduardo J. Molinari, Eduardo Molinari, Molinari, Eduardo

24

Publications

1K

Citations

14

H-Index

29

Concepts

All Affiliations

Abbott FundAbbott (United Kingdom)Abbott (United States)University of Massachusetts Amherst
EM

About

Eduardo Molinari is an author at Abbott Fund specializing in medicine, pharmacology, and melatonin.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

363

2

Natural Sciences

2

2

148

3

Biochemistry

2

2

163

4

Engineering

1

1

85

5

Biology

1

1

85

Eduardo Molinari

×

13

Publications

958

Citations

13

H-Index

YearCitations

Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.

Murali Gopalakrishnan, Lisa M. Monteggia, David J. Anderson,

Journal of Pharmacology and Experimental Therapeutics

1996

176

Regulation of Human α4β2 Neuronal Nicotinic Acetylcholine Receptors by Cholinergic Channel Ligands and Second Messenger Pathways

Murali Gopalakrishnan, Eduardo Molinari, James P. Sullivan

Molecular Pharmacology

1997

131

2-[125I]Iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites

Eduardo Molinari, P. C. NORTH, Margarita L. Dubocovich

European Journal of Pharmacology

1996

110

Characterization of the ATP-Sensitive Potassium Channels (KATP) Expressed in Guinea Pig Bladder Smooth Muscle Cells

Murali Gopalakrishnan, Kristi L. Whiteaker, Eduardo Molinari,

Journal of Pharmacology and Experimental Therapeutics

1999

97

Wild-type gas vesicle formation requires at least ten genes in the gvp gene cluster of Halobacterium halobium plasmid pNRC100

Shiladitya DasSarma, Priya Arora, Feng Lin,

Journal of Bacteriology

1994

85

ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties

James P. Sullivan, Diana L. Donnelly‐Roberts, Clark A. Briggs,

Journal of Pharmacology and Experimental Therapeutics

1997

78

Up-regulation of human α7 nicotinic receptors by chronic treatment with activator and antagonist ligands

Eduardo Molinari, Osvaldo Delbono, Marı́a Laura Messi,

European Journal of Pharmacology

1998

77

The high affinity melatonin binding site probed with conformationally restricted ligands—I. Pharmacophore and minireceptor models

Johanna M. Jansen, Swier Copinga, Gert Gruppen,

Bioorganic & Medicinal Chemistry

1996

53

(−)-(9 S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4 H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. I. In Vitro Characterization

Murali Gopalakrishnan, Steven A. Buckner, Kristi L. Whiteaker,

Journal of Pharmacology and Experimental Therapeutics

2002

41

Genetic and topological analyses of the bop promoter of Halobacterium halobium: stimulation by DNA supercoiling and non-B-DNA structure

Chunqing Yang, Jung Mogg Kim, Eduardo Molinari,

Journal of Bacteriology

1996

38

Page 1